한글목차

압박 요법 시장 규모는 큰 성장이 전망되어 5.5%의 연평균 복합 성장률(CAGR)로 2025년 45억 달러에서 2030년에는 59억 달러로 성장할 전망입니다.

이러한 시장 확대의 배경에는 노인 인구 증가, 만성 정맥 부전의 현저한 증가, 암 치료와 관련된 림프 부종 증가 등 여러 가지 요인이 있습니다. 또한, 앉아서 생활하는 습관과 비만율 증가로 인해 순환 장애가 급증하면서 비침습적 치료 옵션에 대한 수요가 증가하고 있습니다.

제품의 편의성 향상, 눈에 잘 띄지 않는 디자인 개발, 의사의 임상적 인식이 높아지면서 외래 및 재택 압박 요법의 채택이 더욱 확대되고 있습니다. 이러한 추세는 주요 시장에서의 보험 적용 범위 확대와 함께 세계 시장 성장을 지속적으로 촉진하고 있습니다.

탄성복은 정맥류, 림프부종, 만성정맥부전 등의 증상 치료에 널리 사용되어 압박요법 시장을 선도하고 있습니다. 스타킹, 슬리브, 랩을 포함한 이 제품들은 사용하기 쉽고, 다양한 압박 레벨이 있으며, 임상 현장과 재택 간호에 적합해 인기가 높습니다. 수술 후 회복과 고령자나 좌식 생활습관을 가진 사람 등 고위험군에 대한 예방적 치료의 중요성이 높아지면서 수요가 더욱 증가하고 있습니다. 또한, 통기성이 뛰어나고 편안한 원단을 사용하는 등 제품 설계의 지속적인 기술 혁신이 시장에서 지속적인 우위를 점하고 있습니다.

병원 및 클리닉은 압박치료 시장의 주요 유통 경로이며, 특히 공기압 압박 장치 및 고급 치료용 스타킹과 같은 특수 제품의 경우 병원 및 클리닉이 주요 유통 경로입니다. 이들 의료기관은 만성 정맥부전, 림프부종, 수술 후 회복과 같은 증상을 치료하는 데 중요한 역할을 하고 있습니다. 의사의 처방과 추천은 압박 요법 제품에 대한 수요를 촉진하는 데 필수적입니다. 압박 요법이 임상적으로 받아들여지고 있고, 그 이점이 확립되어 있기 때문에 이러한 환경에서 압박 요법이 널리 사용되고 있습니다. 그 결과, 병원 및 클리닉이 주요 판매 채널로 부상하고 있습니다.

이 시장의 성장은 정맥 및 림프 문제가 만연하고 있는 일본과 중국의 고령화 등 여러 요인에 의해 주도되고 있습니다. 또한, 인도와 같은 신흥국의 의료 인식이 높아지고 의료 인프라가 개선되면서 압박 요법 사용이 증가하고 있습니다. 이 지역의 경제 성장으로 인해 가처분 소득이 증가하면서 더 많은 사람들이 이러한 치료용 제품을 구매하고 이용할 수 있게 되었습니다. 이러한 추세는 예방 및 수술 후 치료의 수용성 증가와 함께 아시아태평양 시장 성장을 가속화하고 있습니다.

세계의 압박요법(Compression Therapy) 시장에 대해 조사했으며, 기술별/제품별/용도별/유통 채널별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• Porter의 Five Forces 분석
• 규제 분석
• 상환 시나리오
• 생태계 분석
• 투자 및 자금조달 시나리오
• 기술 분석
• 밸류체인 분석
• 공급망 분석
• 가격 분석
• 특허 분석
• 무역 분석
• 2025-2026년 주요 컨퍼런스 및 이벤트
• 고객의 비즈니스에 영향을 미치는 동향과 혼란
• 주요 이해관계자와 구입 기준
• 미충족 요구와 주요 문제점
• 압박 요법 시장 AI의 영향
• 2025년 미국 관세가 압박 요법 시장에 미치는 영향

제6장 압박 요법 시장(제품별)

• 서론
• 탄성 붕대
• 압박 랩
• 탄성 스타킹
• 압박 테이프
• 공기 압박 장치
• 탄성 브레이스
• 기타

제7장 압박 요법 시장(기술별)

• 서론
• 정적 압박 요법
• 동적 압박 요법

제8장 압박 요법 시장(용도별)

• 서론
• 정맥류 치료
• 심부정맥 혈전증 치료
• 림프액 부종 치료
• 다리 궤양 치료
• 기타

제9장 압박 요법 시장(유통 채널별)

• 서론
• 약국 및 소매점
• E-Commerce 플랫폼
• 병원 및 클리닉
• 홈케어

제10장 압박 요법 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제11장 경쟁 구도

• 서론
• 주요 시장 진출기업의 전략과 강점, 2020년-2024년
• 매출 분석, 2020년-2024년
• 시장 점유율 분석, 2024년
• 기업 평가 매트릭스 : 주요 시장 진출기업, 2024년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2024년
• 기업 평가와 재무 지표
• 제품 및 브랜드 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 시장 진출기업
  • SOLVENTUM CORPORATION(3 M)
  • ENOVIS CORPORATION
  • BSN MEDICAL(A SUBSIDIARY OF ESSITY)
  • CARDINAL HEALTH
  • ARJOHUNTLEIGH
  • TACTILE MEDICAL
  • CONVATEC INC.
  • BIO COMPRESSION SYSTEMS, INC.
  • JUZO GMBH
  • MEDI GMBH & CO. KG
  • PAUL HARTMANN
  • SANYLEG, S.R.L.
  • SIGVARIS GROUP
  • SMITH+NEPHEW
  • MEGO AFEK, LTD.
• 기타 기업
  • GOTTFRIED MEDICAL, INC.
  • THERMOTEK, INC.
  • BAUERFEIND AG
  • OFA BAMBERG GMBH
  • MEDLINE INDUSTRIES
  • ACI MEDICAL
  • AIROS MEDICAL INC.
  • BARCELCOM TEXTEIS, S.A
  • CIZETA MEDICALI S.P.A
  • BOSL MEDIZINTECHNIK

제13장 부록

영문목차

The compression therapy market is expected to experience significant growth, increasing from USD 4.5 billion in 2025 to USD 5.9 billion by 2030, at a CAGR of 5.5%.

This expansion is driven by several factors, including a growing elderly population, a notable rise in chronic venous insufficiency cases, and an increase in lymphedema related to cancer treatments. Additionally, the prevalence of sedentary lifestyles and rising obesity rates has led to a surge in circulatory disorders, creating a higher demand for non-invasive treatment options.

Improvements in product comfort, the development of discreet wearable designs, and increased clinical awareness among physicians have further contributed to the adoption of compression therapy in outpatient and home settings. These trends, along with wider reimbursement coverage in key markets, continue to bolster global market growth.

"Compression garments dominated the market in 2024."

Compression garments lead the compression therapy market due to their extensive use in treating conditions like varicose veins, lymphedema, and chronic venous insufficiency. These products, including stockings, sleeves, and wraps, are popular because they are easy to use, available in various compression levels, and suitable for clinical settings and home care. Their increasing importance in post-surgical recovery and preventive care for at-risk populations, such as the elderly and those with sedentary lifestyles, has further driven demand. Additionally, ongoing innovations in product design, including the use of more breathable and comfortable fabrics, support their continued dominance in the market.

"The hospitals & clinics segment held the largest share of the compression therapy market in 2024."

Hospitals & clinics are the primary distribution channels in the compression therapy market, especially for specialty products such as pneumatic compression devices and advanced therapeutic stockings. These medical facilities play a crucial role in treating conditions like chronic venous insufficiency, lymphedema, and post-surgical recovery. The prescriptions and recommendations made by physicians in clinical settings are vital for driving demand for compression therapy products. The growing clinical acceptance and well-established benefits of compression therapy contribute to its widespread use in these environments. Consequently, hospitals & clinics stand out as the leading distribution channels.

"The Asia Pacific regional segment is expected to register the highest CAGR in the compression therapy market during the forecast period."

The growth in this market is driven by several factors, including an aging population in Japan and China, where venous and lymphatic issues are becoming more prevalent. Additionally, rising healthcare awareness and improvements in medical infrastructure in emerging economies like India are contributing to the increased use of compression therapy. Economic growth in the region is also elevating disposable incomes, enabling more individuals to access and afford these therapeutic products. Together, these trends, along with a growing acceptance of preventive care and post-surgical treatment, are accelerating market growth in the Asia Pacific (APAC) region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)

Prominent players in the compression therapy market include 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), THUASNE (France), among others.

Research Coverage

This market research analyzes the compression therapy market by segmenting it according to product, technique, application, distribution channel, and region. It provides insights into key factors influencing the market, including drivers, restraints, opportunities, and challenges. The report highlights opportunities and challenges for stakeholders and offers a detailed analysis of the competitive landscape, focusing on major market players. Additionally, it examines the micromarkets in greater detail, looking at growth patterns, opportunities, and their contributions to the overall compression therapy market. The report also includes revenue generation forecasts for various market segments and identifies growth opportunities across five key regions.

Key Benefits of Buying this Report

This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, challenges, growth drivers, and opportunities, supporting strategic decision-making through a balanced analysis.

Through this report, readers get insightful views into the following parameters:

The compression therapy market is experiencing growth driven by several key factors, including the increasing prevalence of chronic conditions such as venous insufficiency and lymphedema, which require long-term management. Advances in automated diagnostic tools and smart compression devices are enhancing treatment efficiency and accuracy.

However, high product costs and a lack of awareness in emerging markets constrain this growth. However, there are also significant opportunities for the market, such as product innovation in areas like antimicrobials and custom-fit solutions. Market diversification through new product launches and expansions into untapped regions could further propel growth in the compression therapy market.

Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products in the market

Market Development: The report has elaborated the markets by segmenting the compression therapy market into different regions

Market Diversification: New product launches, unexploited markets, recent developments, and investments in the compression therapy market

Competitive Analysis: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), and THUASNE (France)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Key data from secondary sources
    • 2.1.1.3 Objectives of secondary research
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key primary sources (demand and supply sides)
    • 2.1.2.2 Supply- and demand-side participants
    • 2.1.2.3 Breakdown of primary interviews: By company type, designation, and region
    • 2.1.2.4 Objectives of primary research
    • 2.1.2.5 Insights from industry experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation
    • 2.2.1.2 Approach 2: Customer-based market estimation
    • 2.2.1.3 Approach 3: Primary interviews
  • 2.2.2 BOTTOM-UP APPROACH
• 2.3 GROWTH RATE ASSUMPTIONS
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN COMPRESSION THERAPY MARKET
• 4.2 COMPRESSION THERAPY MARKET, BY REGION
• 4.3 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY AND DISTRIBUTION CHANNEL
• 4.4 COMPRESSION THERAPY MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Large target patient population
    • 5.2.1.2 Growing incidence of sports injuries and accidents
    • 5.2.1.3 Increasing number of orthopedic procedures
    • 5.2.1.4 Greater product affordability and market availability
    • 5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Lack of universally accepted standards for compression products
    • 5.2.2.2 Low patient compliance with compression garments
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth potential offered by emerging markets
    • 5.2.3.2 Growing patient awareness regarding benefits of compression therapy
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Significant adoption of alternative therapies for specific target indications
    • 5.2.4.2 Increasing pricing pressure on market players
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY ANALYSIS
    • 5.4.1.1 US
    • 5.4.1.2 Canada
    • 5.4.1.3 Europe
    • 5.4.1.4 Japan
  • 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.5 REIMBURSEMENT SCENARIO
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT & FUNDING SCENARIO
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Pneumatic compression devices
    • 5.8.1.2 Smart compression garments
    • 5.8.1.3 Static compression devices
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Digital connectivity (telehealth platforms)
    • 5.8.2.2 Value-added software (AI & IOT)
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Custom-fitted compression garments
• 5.9 VALUE CHAIN ANALYSIS
  • 5.9.1 RESEARCH & DEVELOPMENT
  • 5.9.2 RAW MATERIAL PROCUREMENT & PRODUCT MANUFACTURING
  • 5.9.3 DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES
• 5.10 SUPPLY CHAIN ANALYSIS
  • 5.10.1 PROMINENT COMPANIES
  • 5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.10.3 END USERS
• 5.11 PRICING ANALYSIS
  • 5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE
  • 5.11.2 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY DEVICES, BY PRODUCT TYPE, 2022-2024
  • 5.11.3 AVERAGE SELLING PRICE TREND OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022-2024
  • 5.11.4 AVERAGE SELLING PRICE OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022-2024
  • 5.11.5 AVERAGE SELLING PRICE TREND OF COMPRESSION BRACES, BY KEY PLAYER, 2022-2024
  • 5.11.6 AVERAGE SELLING PRICE OF COMPRESSION BRACES, BY KEY PLAYER, 2022-2024
  • 5.11.7 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS, BY REGION, 2022-2024
  • 5.11.8 AVERAGE SELLING PRICE OF COMPRESSION THERAPY PRODUCTS, BY REGION, 2022-2024
• 5.12 PATENT ANALYSIS
• 5.13 TRADE ANALYSIS
  • 5.13.1 IMPORT SCENARIO (HS CODE 611510)
  • 5.13.2 EXPORT SCENARIO (HS CODE 611510)
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 UNMET NEEDS & KEY PAIN POINTS
• 5.18 IMPACT OF AI ON COMPRESSION THERAPY MARKET
• 5.19 IMPACT OF 2025 US TARIFF ON COMPRESSION THERAPY MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES

6 COMPRESSION THERAPY MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 COMPRESSION BANDAGES
  • 6.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH
• 6.3 COMPRESSION WRAPS
  • 6.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET
• 6.4 COMPRESSION STOCKINGS
  • 6.4.1 CLASS I COMPRESSION STOCKINGS
    • 6.4.1.1 Advantages such as comfort and durability to drive demand for Class I stockings
  • 6.4.2 CLASS II COMPRESSION STOCKINGS
    • 6.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand
  • 6.4.3 CLASS III COMPRESSION STOCKINGS
    • 6.4.3.1 High level of compression provided to boost adoption of Class III stockings
• 6.5 COMPRESSION TAPES
  • 6.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES
• 6.6 PNEUMATIC COMPRESSION DEVICES
  • 6.6.1 INTERMITTENT COMPRESSION DEVICES
    • 6.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand
  • 6.6.2 SEQUENTIAL COMPRESSION DEVICES
    • 6.6.2.1 Wide usage for DVT prevention to boost growth
• 6.7 COMPRESSION BRACES
  • 6.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET
• 6.8 OTHER COMPRESSION GARMENTS

7 COMPRESSION THERAPY MARKET, BY TECHNIQUE

• 7.1 INTRODUCTION
• 7.2 STATIC COMPRESSION THERAPY
  • 7.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH
• 7.3 DYNAMIC COMPRESSION THERAPY
  • 7.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET

8 COMPRESSION THERAPY MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 VARICOSE VEIN TREATMENT
  • 8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET
• 8.3 DEEP VEIN THROMBOSIS TREATMENT
  • 8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH
• 8.4 LYMPHEDEMA TREATMENT
  • 8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH
• 8.5 LEG ULCER TREATMENT
  • 8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET
• 8.6 OTHER APPLICATIONS

9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL

• 9.1 INTRODUCTION
• 9.2 PHARMACIES & RETAILERS
  • 9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH
• 9.3 E-COMMERCE PLATFORMS
  • 9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD
• 9.4 HOSPITALS & CLINICS
  • 9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH
• 9.5 HOME CARE SETTINGS
  • 9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET

10 COMPRESSION THERAPY MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Rising number of sports injuries to drive market growth
  • 10.2.3 CANADA
    • 10.2.3.1 Increasing incidence of target diseases to support growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Inconsistent reimbursement for compression therapy products to restrain market growth
  • 10.3.3 FRANCE
    • 10.3.3.1 High incidence of diabetes to drive demand for compression therapy
  • 10.3.4 UK
    • 10.3.4.1 Rising prevalence of lymphedema and DVT to drive market
  • 10.3.5 ITALY
    • 10.3.5.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing presence of key manufacturers to increase access to compression therapy products
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Modernization of healthcare facilities to drive market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Japan to dominate Asia Pacific compression therapy market
  • 10.4.4 INDIA
    • 10.4.4.1 Growing number of hip & knee surgeries to support market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Government subsidies related to compression garments for lymphedema patients to promote growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Increasing number of plastic surgeries to drive demand for compression garments
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Rising number of cosmetic surgeries to support market
  • 10.5.3 MEXICO
    • 10.5.3.1 Lack of reimbursement for bracing products to limit growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Significant investments in healthcare to boost growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 COMPRESSION STOCKINGS MARKET SHARE
  • 11.4.2 COMPRESSION BANDAGES MARKET SHARE
  • 11.4.3 PNEUMATIC COMPRESSION DEVICES MARKET SHARE
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 Technique footprint
    • 11.5.5.6 Distribution channel footprint
• 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPANY BENCHMARKING: START-UPS/SMES, 2024
    • 11.6.5.1 List of start-ups/SMEs
    • 11.6.5.2 Competitive benchmarking of start-ups/SMEs
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
• 11.8 PRODUCT/BRAND COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES & APPROVALS
  • 11.9.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 SOLVENTUM CORPORATION (3M)
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches & approvals
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 ENOVIS CORPORATION
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 BSN MEDICAL (A SUBSIDIARY OF ESSITY)
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 CARDINAL HEALTH
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches & approvals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 ARJOHUNTLEIGH
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 MnM view
      • 12.1.5.3.1 Key strengths
      • 12.1.5.3.2 Strategic choices
      • 12.1.5.3.3 Weaknesses & competitive threats
  • 12.1.6 TACTILE MEDICAL
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches
  • 12.1.7 CONVATEC INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
  • 12.1.8 BIO COMPRESSION SYSTEMS, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 JUZO GMBH
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
  • 12.1.10 MEDI GMBH & CO. KG
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 PAUL HARTMANN
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Deals
  • 12.1.12 SANYLEG, S.R.L.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
  • 12.1.13 SIGVARIS GROUP
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Deals
  • 12.1.14 SMITH+NEPHEW
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Expansions
  • 12.1.15 MEGO AFEK, LTD.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 GOTTFRIED MEDICAL, INC.
  • 12.2.2 THERMOTEK, INC.
  • 12.2.3 BAUERFEIND AG
  • 12.2.4 OFA BAMBERG GMBH
  • 12.2.5 MEDLINE INDUSTRIES
  • 12.2.6 ACI MEDICAL
  • 12.2.7 AIROS MEDICAL INC.
  • 12.2.8 BARCELCOM TEXTEIS, S.A
  • 12.2.9 CIZETA MEDICALI S.P.A
  • 12.2.10 BOSL MEDIZINTECHNIK

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS